...
首页> 外文期刊>International journal of stroke: official journal of the International Stroke Society >Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study
【24h】

Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study

机译:中国卒中房颤患者口服抗凝药的使用:ChinaQUEST(卒中治疗和治疗质量评估)注册研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background International guidelines recommend oral anti-coagulation in patients with atrial fibrillation according to their level of stroke risk. This study aimed to determine oral anticoagulation use in atrial fibrillation patients with recent ischemic stroke and examine factors that impact such management in China.Methods Among the patients with acute ischemic stroke (n = 4782) from the China QUality Evaluation of Stroke Care and Treatment study, a multicenter, prospective, 62-hospital registry in China, there were 499 (10%) (mean age 70 ± 12 years, 49% female) with documented atrial fibrillation with outcome data over 12 months of follow-up. Logistic regression analysis was used to identify the independent predictors of oral anticoagulation use in these patients.
机译:背景技术国际指南建议根据房颤患者的房颤风险水平对他们进行口服抗凝治疗。这项研究的目的是确定在近期缺血性中风的房颤患者中口服抗凝药物的使用,并探讨影响中国这种治疗的因素。中国中风护理和治疗质量评估研究中的急性缺血性中风患者(n = 4782) ,这是一个在中国拥有62所医院的多中心,前瞻性注册机构,在记录的心房颤动中,有499名(10%)(平均年龄70±12岁,女性占49%),其随访结果超过12个月。使用Logistic回归分析来确定这些患者口服抗凝药的独立预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号